Scott A. Bergfeld, Ph.D. - Publications
Affiliations: | 2013 | Pathobiology | University of Southern California, Los Angeles, CA, United States |
Area:
Oncology, Immunology, PathologyYear | Citation | Score | |||
---|---|---|---|---|---|
2014 | Bergfeld SA, Blavier L, DeClerck YA. Bone marrow-derived mesenchymal stromal cells promote survival and drug resistance in tumor cells. Molecular Cancer Therapeutics. 13: 962-75. PMID 24502925 DOI: 10.1158/1535-7163.Mct-13-0400 | 0.641 | |||
2013 | Bergfeld SA, DeClerck YA. Mesenchymal stem cells and the tumor microenvironment Stem Cell-Dependent Therapies: Mesenchymal Stem Cells in Chronic Inflammatory Disorders. 331-352. DOI: 10.1515/9783110298307.331 | 0.845 | |||
2008 | Sadun RE, Hsu WE, Zhang N, Nien YC, Bergfeld SA, Sabzevari H, Lutsiak ME, Khawli L, Hu P, Epstein AL. Fc-mOX40L fusion protein produces complete remission and enhanced survival in 2 murine tumor models. Journal of Immunotherapy (Hagerstown, Md. : 1997). 31: 235-45. PMID 18317364 DOI: 10.1097/CJI.0b013e31816a88e0 | 0.519 | |||
Show low-probability matches. |